Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00505 | 6-Maleimidocaproic acid sulfo-NHS | 103848-61-9 |
| 6-Maleimidocaproic acid sulfo-NHS is a small molecule reagent used in the biomedical industry. It is commonly used to modify biomolecules, such as proteins and antibodies, for site-specific conjugation. This compound enables the efficient and stable attachment of drugs, tags, or targeting moieties to these biomolecules, thereby facilitating the development of innovative treatments for a variety of diseases, including cancer and autoimmune diseases. | Inquiry | |
| BADC-00506 | GMBS | 80307-12-6 |
| GMBS is a non-cleavable linker widely used in antibody-drug conjugation development. Its unparalleled efficacy stems from its chemical cross-linking ability, promoting the covalent binding of proteins, peptides, antibodies and countless other molecules. Notably, GMBS occupies a key position in the fields of drug delivery systems, diagnostics, and evolving bioconjugation technologies. | Inquiry | |
| BADC-00507 | N-Hydroxysuccinimidyl-4-azidobenzoate | 53053-08-0 |
| N-Hydroxysuccinimidyl-4-azidobenzoate is a non-cleavable linker in the field of antibody drug conjugation and has been widely used in the field of bioconjugation and cross-linking. Its key role is to facilitate the development of targeted drug delivery systems and diagnostic tools of paramount importance. By creating covalent bonds between biomolecules and multiple agents or interfaces, it provides a way to precisely target and manage diseases such as cancer, autoimmune abnormalities, and infectious diseases. | Inquiry | |
| BADC-00508 | SPDPH | 158913-22-5 |
| SPDPH is a biochemical product used in cancer drug development. It acts as a linker moiety for attaching biomolecules to surfaces or to each other. The product plays a key role in drug delivery systems, cancer diagnostics and targeted therapies. SPDPH enables the targeted delivery of drugs and diagnostics, thereby increasing the efficacy and specificity of cancer treatments. | Inquiry | |
| BADC-00509 | MTS-4-NHS | 690632-55-4 |
| Inquiry | ||
| BADC-00512 | m-PEG1-NHS ester | 1027371-75-0 |
| m-PEG1-NHS ester is a PEG derivative containing an NHS ester. The NHS ester can be used to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules. The hydrophilic PEG spacer increases solubility in aqueous media. m-PEG1-NHS ester is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00513 | (2S,2'S)-Bis(2,5-Dioxopyrrolidin-1-yl) 4,4'-Disulfanediylbis(2-Acetamidobutanoate) | 102814-00-6 |
| (2S, 2'S)-Bis(2, 5-dioxopyrrolidin-1-yl)4, 4'-disulfanediylbis(2-acetamidobutanoate) is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00514 | 2-(2-(2-(3-((2,5-Dioxopyrrolidin-1-yl)oxy)-3-Oxopropoxy)ethoxy)ethoxy)ethyl Acrylate | 1042435-35-7 |
| 2-(2-(2-(3-((2, 5-Dioxopyrrolidin-1-yl)oxy)-3-oxopropoxy)ethoxy)ethoxy)ethyl acrylate is a PEG linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00515 | 2,5-Dioxopyrrolidin-1-yl 2,5,7,10-Tetraoxatridecan-13-Oate | 1053657-02-5 |
| 2, 5-Dioxopyrrolidin-1-yl 2, 5, 7, 10-tetraoxatridecan-13-oate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00516 | Sulfo-SIAB | 106145-13-5 |
| Sulfo-SIAB is a nonclaevable monovalent bilinker. | Inquiry | |
| BADC-00517 | 4-Formyl-N-(2-Isopropoxyethyl)benzamide | 1061567-05-2 |
| 4-Formyl-N-(2-isopropoxyethyl)benzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00518 | AcS-PEG8-NHS | 1070798-99-0 |
| AcS-PEG8-NHS contains an acetyl-protected thiol and an amine-reactive N-hydroxysuccinimide (NHS) ester. Although it is commonly used for proteins, it is also suitable for any small molecules or peptides with suitable functionalities. | Inquiry | |
| BADC-00519 | m-PEG2-NHS ester | 1127247-34-0 |
| m-PEG2-NHS ester is a single molecular weight PEG linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00520 | 2,5-Dioxopyrrolidin-1-yl 3-(benzyloxy)propanoate | 1134280-63-9 |
| 2, 5-Dioxopyrrolidin-1-yl 3-(benzyloxy)propanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00521 | 2,5-Dioxopyrrolidin-1-yl 3-((2-Fluorobenzyl)oxy)propanoate | 1134280-64-0 |
| 2, 5-Dioxopyrrolidin-1-yl 3-((2-fluorobenzyl)oxy)propanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00522 | 2,5-Dioxopyrrolidin-1-yl 3-((2,4-Difluorobenzyl)oxy)propanoate | 1134280-65-1 |
| 2, 5-Dioxopyrrolidin-1-yl 3-((2, 4-difluorobenzyl)oxy)propanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00523 | N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide | 1137575-49-5 |
| N-(2-(2-Chloroethoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00524 | Mal-Tetra-EG-Osu | 1151762-45-6 |
| Mal-Tetra-EG-OSu is a PEG linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00525 | Propanoic Acid,3-[(23-Mercapto-3,6,9,12,15,18,21-Heptaoxatricos-1-Yl)oxy], 2,5-Dioxo-1-Pyrrolidinyl Ester | 1159006-15-1 |
| Propanoic Acid, 3-[(23-mercapto-3, 6, 9, 12, 15, 18, 21-heptaoxatricos-1-yl)oxy], 2, 5-dioxo-1-pyrrolidinyl Ester is a PEGn linker for antibody-drug-conjugation (ADC). | Inquiry | |
| BADC-00526 | 2,5-Dioxopyrrolidin-1-yl 4-((2-(1,3-Dioxoisoindolin-2-Yl)ethyl)disulfanyl)butanoate | 1190203-91-8 |
| 2, 5-Dioxopyrrolidin-1-yl 4-((2-(1, 3-dioxoisoindolin-2-yl)ethyl)disulfanyl)butanoate is a linker for antibody-drug-conjugation (ADC). | Inquiry |
